Benefits of new drugs pose unexpected dilemmas.  [electronic resource] 

 -  AIDS alert  Mar 1997 
 - 25-7 p.  digital 
<br/><br/> Publication Type: Newspaper Article; Journal Article 
<br/><br/><label>ISSN: </label>0887-0292 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AIDS-Related Opportunistic Infections--drug therapy<br/>Acquired Immunodeficiency Syndrome--drug therapy<br/>Bed Occupancy<br/>CD4 Lymphocyte Count<br/>Disability Evaluation<br/>Persons with Disabilities--legislation & jurisprudence<br/>Drug Therapy, Combination<br/>HIV Infections--drug therapy<br/>HIV Protease Inhibitors--therapeutic use<br/>Hospices<br/>Hospitalization<br/>Humans<br/>Insurance Benefits<br/>Length of Stay<br/>Mycobacterium avium-intracellulare Infection--drug therapy<br/>Social Security<br/>United States